Literature DB >> 34926204

Aqueous angiopoietin-like levels correlate with optical coherence tomography angiography metrics in diabetic macular edema.

Jie Yan1,2, Wu-Jun Li2, Ya-Zhou Qin1, Xuan-Yu Qiu1, Li Qin1, Jing-Ming Li1.   

Abstract

AIM: To quantitatively detect aqueous levels of angiopoietin-like (ANGPTL)3, ANGPTL4, and ANGPTL6 and investigate their correlation with optical coherence tomography angiography (OCTA) findings in patients with diabetic macular edema (DME).
METHODS: This cross-sectional study included 23 patients (27 eyes) with type 2 diabetes and 16 control subjects (20 eyes). All patients underwent OCTA imaging and ultra-wide field fundus photography. Diabetic patients were categorized into two groups according to the presence or absence of diabetic retinopathy (DME group, 14 patients, 16 eyes); and non-diabetic retinopathy (NDR) group, 9 patients, 11 eyes, respectively. Aqueous levels of ANGPTL3, ANGPTL4, and ANGPTL6 were assessed using suspension array technology, and foveal-centered 3×3 mm2 OCTA scans were automatically graded to determine the central, inner, and full vessel density (CVD, IVD, FVD); central, inner, and full perfusion density (CPD, IPD, FPD), foveal avascular zone (FAZ) area, FAZ perimeter, and FAZ circularity index (FAZ-CI) on superficial capillary plexuses. Additionally, central subfield thickness (CST), cube volume (CV), and cube average thickness (CAT) were measured in a model of macular cube 512×128.
RESULTS: Aqueous ANGPTL3 levels were not significantly different among the three groups (P>0.05). ANGPTL4 levels were significantly higher in the DME group than the control and NDR groups (P<0.0001 and P<0.001), while ANGPTL6 levels were significantly higher in the DME group than the control group (P<0.05). In the whole cohort, the aqueous ANGPTL3 levels correlated negatively with the IVD, FVD, IPD, and FPD, and positively with the CV and CAT. The aqueous ANGPTL4 levels correlated negatively with the CVD, IVD, FVD, CPD, IPD, and FPD, and positively with the FAZ perimeter, CST, CV, and CAT. The aqueous ANGPTL6 levels correlated negatively with the IVD, FVD, IPD, FPD, FAZ-CI and positively with CST, CV, CAT.
CONCLUSION: ANGPTL4 and ANGPTL6 may be associated with vascular leakage in DME and may represent good targets for DME therapy. In addition, OCTA metrics may be useful for evaluating macular ischemia in DME. International Journal of Ophthalmology Press.

Entities:  

Keywords:  angiopoietin-like; diabetic macular edema; diabetic retinopathy; optical coherence tomography angiography; vascular leakage

Year:  2021        PMID: 34926204      PMCID: PMC8640760          DOI: 10.18240/ijo.2021.12.12

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  41 in total

Review 1.  Emerging roles of angiopoietin-like 4 in human cancer.

Authors:  Ming Jie Tan; Ziqiang Teo; Ming Keat Sng; Pengcheng Zhu; Nguan Soon Tan
Journal:  Mol Cancer Res       Date:  2012-06-01       Impact factor: 5.852

2.  Angiopoietin-like 3 Is a Potential Biomarker for Retinopathy in Type 2 Diabetic Patients.

Authors:  Cai-Guo Yu; Sha-Sha Yuan; Long-Yan Yang; Jing Ke; Li-Jie Zhang; Jia-Nan Lang; Da-Wei Zhang; Shao-Zhen Zhao; Dong Zhao; Ying-Mei Feng
Journal:  Am J Ophthalmol       Date:  2018-04-03       Impact factor: 5.258

3.  Identification of a mammalian angiopoietin-related protein expressed specifically in liver.

Authors:  D Conklin; D Gilbertson; D W Taft; M F Maurer; T E Whitmore; D L Smith; K M Walker; L H Chen; S Wattler; M Nehls; K B Lewis
Journal:  Genomics       Date:  1999-12-15       Impact factor: 5.736

Review 4.  Diabetic macular oedema.

Authors:  Gavin S Tan; Ning Cheung; Rafael Simó; Gemmy C M Cheung; Tien Yin Wong
Journal:  Lancet Diabetes Endocrinol       Date:  2016-08-03       Impact factor: 32.069

Review 5.  Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-analysis From 1990 to 2010.

Authors:  Janet L Leasher; Rupert R A Bourne; Seth R Flaxman; Jost B Jonas; Jill Keeffe; Kovin Naidoo; Konrad Pesudovs; Holly Price; Richard A White; Tien Y Wong; Serge Resnikoff; Hugh R Taylor
Journal:  Diabetes Care       Date:  2016-09       Impact factor: 19.112

6.  Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene.

Authors:  S Kersten; S Mandard; N S Tan; P Escher; D Metzger; P Chambon; F J Gonzalez; B Desvergne; W Wahli
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

7.  Early Response to Anti-Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes With Diabetic Macular Edema in Protocol T.

Authors:  Neil M Bressler; Wesley T Beaulieu; Maureen G Maguire; Adam R Glassman; Kevin J Blinder; Susan B Bressler; Victor H Gonzalez; Lee M Jampol; Michele Melia; Jennifer K Sun; John A Wells
Journal:  Am J Ophthalmol       Date:  2018-08-02       Impact factor: 5.258

8.  Optical Coherence Tomographic Angiography in Type 2 Diabetes and Diabetic Retinopathy.

Authors:  Daniel Shu Wei Ting; Gavin Siew Wei Tan; Rupesh Agrawal; Yasuo Yanagi; Nicole Ming Sie; Chee Wai Wong; Ian Yew San Yeo; Shu Yen Lee; Chui Ming Gemmy Cheung; Tien Yin Wong
Journal:  JAMA Ophthalmol       Date:  2017-04-01       Impact factor: 7.389

Review 9.  Global prevalence and major risk factors of diabetic retinopathy.

Authors:  Joanne W Y Yau; Sophie L Rogers; Ryo Kawasaki; Ecosse L Lamoureux; Jonathan W Kowalski; Toke Bek; Shih-Jen Chen; Jacqueline M Dekker; Astrid Fletcher; Jakob Grauslund; Steven Haffner; Richard F Hamman; M Kamran Ikram; Takamasa Kayama; Barbara E K Klein; Ronald Klein; Sannapaneni Krishnaiah; Korapat Mayurasakorn; Joseph P O'Hare; Trevor J Orchard; Massimo Porta; Mohan Rema; Monique S Roy; Tarun Sharma; Jonathan Shaw; Hugh Taylor; James M Tielsch; Rohit Varma; Jie Jin Wang; Ningli Wang; Sheila West; Liang Xu; Miho Yasuda; Xinzhi Zhang; Paul Mitchell; Tien Y Wong
Journal:  Diabetes Care       Date:  2012-02-01       Impact factor: 19.112

10.  Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy.

Authors:  Savalan Babapoor-Farrokhran; Kathleen Jee; Brooks Puchner; Syed Junaid Hassan; Xiaoban Xin; Murilo Rodrigues; Fabiana Kashiwabuchi; Tao Ma; Ke Hu; Monika Deshpande; Yassine Daoud; Sharon Solomon; Adam Wenick; Gerard A Lutty; Gregg L Semenza; Silvia Montaner; Akrit Sodhi
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.